ClinicalTrials.gg
Active, not recruitingNCT05388097Updated Nov 20, 2026

Effect of a Quality Improvement Initiative to Address Social Determinants of Health on Rehospitalization Rates in Patients With Heart Failure

An interventional study of Managed Services in Heart Failure, sponsored by Saint Luke's Health System. Active, not recruiting at 3 sites in United States. Open to participants aged 18 Years to 99 Years. Per ClinicalTrials.gov, last updated 2026-11-20.

Sponsored by Saint Luke's Health System · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Registered 11 months after the study started (first participant enrolled May 2021, registered Apr 2022).
Updated Nov 20, 2026Now Active, not recruitingPrimary completion moved+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
320
Allocation
Randomized
Ages
18 Years to 99 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 2,159 studies in Heart Failure with a site in United States — 346 open to participants now, 439 under way, 27 of them phase 3. Heart Failure · United States.

Planned enrollment
344th of 1,602
320 · median 66
Started
2021
with 104 others
No phase
887 of 2,159
159 open now
Primary completion
2027-12
later than 258 of 438 live
Registered
1,682nd of 2,159
by date

Among the 2,159 studies in Heart Failure with a site in United States, this one is the 344th largest by planned enrollment of the 1,602 interventional ones that give a count, is one of 105 that started in 2021, is one of 887 with no phase, reaches primary completion later than 258 of the 438 other live ones, and was the 1,682nd registered.

Heart Failure

6,340 studies on the registry are indexed under Heart Failure; 1,397 are open to participants now.

Browse Heart Failure studies →

Open to participants now

346 of the 2,159 studies in Heart Failure with a site in United States are open now. Recruiting first, the newest first:

341 more — sign in →

All 346 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 968 Heart Failure studies recruiting now, 691 (71%) set no upper age limit and 90 (9%) stop at 75 or younger; 64 take children under 18; 97 take healthy volunteers.

This study: 18 Years to 99 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 2,159 studies in Heart Failure with a site in United States, or all of them as a file.
02

Study summary

The objective of this program is to improve post-acute care coordination for necessary social services for patients leaving the hospital after recovering from an episode of decompensated heart failure.

03

Conditions studied

  • Heart Failure

Browse trials for

Keywords

  • heart failure
04

Who can participate

Ages eligible
18 Years to 99 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged 18-99 years
  • Resident of Missouri or Kansas
  • Current inpatient admission for acute heart failure

Exclusion criteria

Exclusion Criteria:

  • Under 18 years or over 99 years of age
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
320 participants (estimated)

Study arms

  • No intervention
    Standard Of Care - No Managed Services

    Subjects receive standard medical care and follow-up after hospital discharge

  • Experimental
    Managed Services After Discharge

    Subjects receive in-home assessment and care coordination/connection with community resources after hospital discharge

    Other: Managed Services

Interventions

  • OtherManaged Services

    coordination of care and assistance with community resources (food, transportation)

06

What researchers measure

Primary outcomes

  1. Reduction in all-cause re-hospitalization

    reduction in all-cause re-hospitalization via improved post-acute care coordination

    Time frame: 2 years

07

Study locations

3 sites
08

References and documents

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started May 2021 (actual). Primary completion is estimated for Dec 2027, 79 months after the start.

Of 1,119 non-industry interventional studies with no phase under Heart Failure, half reached primary completion within 29 months of starting (the median), counting those still running; a quarter within 16 and three quarters within 50. This study's planned 79 months is above that.

Counting every sponsor, half of 1,355 studies reached it within 31 months; a quarter within 16 and three quarters within 52.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 20, 2026: primary completion Dec 2025 → Dec 2027 and completion Jun 2026 → Jun 2028.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Apr 27, 2022
First posted
May 24, 2022
StartActual
May 3, 2021
Primary completionEst.
Dec 2027was Dec 2025
CompletionEst.
Jun 2028was Jun 2026
Last update
Nov 20, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Recruiting→Active, not recruiting
changed Nov 20, 2026
Primary completion
Dec 2025→Dec 2027
Nov 20, 2026
Study completion
Jun 2026→Jun 2028
Nov 20, 2026
Show all 1 update
  1. Nov 20, 2026
    Recruiting→Active, not recruiting
    Primary completion Dec 2025→Dec 2027
    Study completion Jun 2026→Jun 2028
    + 3 other changes: verification date, contact details and site details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT05388097
Lead sponsor
Saint Luke's Health System
Collaborators
Truman Medical Center, University of Missouri, Kansas City, Mid America Regional Council
Responsible party
Sponsor
First posted
May 24, 2022
Start date
May 3, 2021
Primary completion
Dec 2027 (estimated)
Completion
Jun 2028 (estimated)
Last update
Nov 20, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion